Company profile

MiNK Therapeutics, Inc. Insider Trading

INKT

Every SEC Form 4 insider trading filing for MiNK Therapeutics, Inc. (INKT) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
CIK
0001840229
Filings
96
Insiders
11
Last filing
2026-06-04

Activity summary

No insider transactions in the last 30 days. The most recent was on June 4, 2026, when Ryan Barbara sold 500 shares. 96 filings from 11 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q3 23 to Q2 26. MiNK Therapeutics, Inc. insiders are net buyers across the period shown.

Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $406K.

90 day insight

Over the last 90 days, MiNK Therapeutics, Inc. insiders bought $79K (5 transactions) and sold $19K (2 transactions).

  • Most active insider: Ryan Barbara with 3 transactions totaling $37K.
  • Largest single purchase: $18K by Corvese Brian on Jun 1, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Ryan BarbaraINKT
Sale
500$12.68$6K
Jun 4, 2026Ryan BarbaraINKT
Sale
1,000$12.80$13K
Jun 1, 2026Holcomb John BradleyINKT
Award
1,091$12.38$14K
Jun 1, 2026Wiinberg UlfINKT
Award
1,131$12.38$14K
Jun 1, 2026Behner PeterINKT
Award
1,313$12.38$16K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=INKT" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Buell JenniferSee Remarks3 filings+$86K
Ryan Barbara14 filings+$60K
Corvese Brian5 filings+$89K
Behner Peter5 filings+$81K
Wiinberg Ulf5 filings+$70K

Institutional Ownership

Top 13F-HR holders of MiNK Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$363,594
QoQ change
Reporting period
2026-06-30
#1
Longbow Finance SA
CIK 0001965552
$194,837
17K shares
#2
BlackRock, Inc.
CIK 0002012383
$78,720
7K shares
#3
BlackRock, Inc.
CIK 0002012383
$71,753
6K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →